Release Date: December 21, 2017
Expiration Date: December 21, 2018
Media: Internet - based
This educational activity will define the unique aspects of care that practitioners provide to patients with psoriasis, including facilitating conversations about managing disease, setting expectations, and selecting treatment options, including when treatment response or tolerability is suboptimal. The importance of relationship building also will be explored. Practical strategies to address patient barriers, including lack of knowledge about psoriasis, fear of injections, and adverse effect risks will be provided. By engaging patients in their psoriasis care plans, family physicians can optimize outcomes and manage psoriasis and its comorbidities.
Please note that there are several patient cases presented throughout the activity revolving around screening, diagnosis, and treatment for psoriasis and psoriatic arthritis. These cases provide a wide variety of patient scenarios that may be applicable to many different practice settings. All of the cases are available for your review in the PDF provided within the activity.
Instructions for This Activity and Receiving Credit
Physicians and Family Medicine Physicians
At the conclusion of this educational activity, participants will be able to:
Paul Doghramji, MD, FAAFP
Family Practice Physician
Collegeville Family Practice
Pottstown Medical Specialists, Inc.
Medical Director of Health Services
Disclosure: Consultant: Purdue Pharma, Ironwood Pharma, Merck; Speakers Bureau: Merck; Stock/Shareholder: Pfizer
Arthur M. Mandelin, MD, PhD
Assistant Professor of Medicine (Rheumatology)
Northwestern University Feinberg
School of Medicine
Disclosure: Grant/Research Support: Pfizer; Consultant: Cardinal Health, Crescendo, Horizon, Pfizer; Speakers Bureau: AbbVie, Genentech, Sanofi, UCB
Jashin J. Wu, MD, FAAD
Director of Dermatology Research
Los Angeles Medical Center
Los Angeles, California
Disclosure: Grant/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Regeneron
Psoriasis Patient Advocate
The staff of PER® have no relevant financial relationships with commercial interests to disclose.
Global Education Group and Physicians’ Education Resource®, LLC (PER®) (formerly ArcMesa Educators) strive to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars, hosted by PER®. PER® reserves the right to cancel an event without notice. PER® will not be responsible for any expenditure incurred due to the cancellation.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER® do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Dec 31, 2018
Medical Crossfire®: Defining New Roles for the Application of PARP Inhibition Strategies in Multiple Tumor Types
Dec 31, 2018
Dec 31, 2018